Efficacy of parecoxib for the treatment of postoperative shivering in patients undergoing general anesthesia

Efficacy of parecoxib for the treatment of postoperative shivering in patients undergoing general anesthesia - Parecoxib and shivering

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013226

Enrollment

Registered

2014-02-22

Start date

2014-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing general anesthesia were recruited into the study

Interventions

In group P, intravenous parecoxib (40mg) was given. In group T, intravenous tramadol (2mg/kg) was given.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adult patients (ASA physical status I or II) scheduled for elective gastrointestinal surgery under general anesthetic combined with epidural block were included in this study.

Exclusion criteria

Exclusion criteria: 1, initial body temperature more than 38 centigrade or less than 36.5 centigrade; 2, hyperthyroidism, hypertension, diabetes mellitus, impaired renal or liver functions, endocrine or cardiopulmonary disease; 3, taking vasoactive or antidepressant drugs, receiving intraoperative blood or blood products transfusion; 4, known history of alcohol or substance abuse, or possible pregnancy;

Design outcomes

Primary

Measure	Time frame
shivering grade	—

Countries

Asia(except Japan)

Contacts

Public ContactChen jie

Third Military Medical University Department of Anaesthesiology, Southwest Hospital,

cjandsh@tmmu.edu..cn+81-086-23-68754197

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026